Infectious Enteritis Treatment Market

Infectious Enteritis Treatment Market : Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

  • Ongoing
  • July 2020
  • REP-GB-11251
Infectious Enteritis Treatment Market

  • US$5,000
  • US$7,500
  • US$10,000

This Infectious Enteritis Treatment market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Infectious Enteritis Treatment market.

Enteritis is inflammation of the small intestine. The major cause of enteritis is contaminated food and water with bacteria or viruses. Bacterial agents like Escherichia coli, toxigenic Clostridium difficileCampylobacter jejuni, and Vibrio cholerae are the major causes of infectious enteritis and disease is commonly known as bacteremia. These infectious agents then settle down in small intestine and cause swelling or inflammation. The major symptoms of infectious enteritis include fever, nausea, vomiting, diarrhoea etc. Among all the symptoms diarrhoea is highly prevalent. Disease conditions are most seen in under developed regions due to lack of awareness for personal hygiene and minimal healthcare expenditures. Initial infectious enteritis treatment may include fluid or electrolyte rehydration (ORS) and sometimes intravenous fluids. Ampicillin, Trimethoprim-sulfamethoxazole, Chloramphenicol, Tetracycline can be the first choice of antibacterial agents for infectious enteritis treatment. But with course of use these agents have developed resistance towards bacterial agents and hence probiotics can be the safest mode for infectious enteritis treatment. Lactobacillus reuteri, Lactobacillus rhamnosus, and the probiotic yeast Saccharomyces boulardii can help to treat diarrhoeal conditions in humans.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Infectious Enteritis Treatment Market: Drivers and Restraints

The rising population of diarrheal cases due to infectious enteritis especially in children is the major factor driving the growth of the infectious enteritis treatment market. According to WHO globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. These increasing prevalence of disease will help in driving the growth of infectious enteritis treatment market. The increasing application of drugs for the treatment of infectious enteritis such as Chloramphenicol and tetracycline are further expected to surge the growth of the infectious enteritis treatment market. Increasing FDA approvals of infectious enteritis treatment drugs are further expected to aid in the growth of the infectious enteritis treatment market. Intensive research and development activities to expand the therapeutic applications of infectious enteritis treatment drugs are further anticipated to support the growth of the infectious enteritis treatment market during the forecast years. The presence of a huge number of infectious enteritis treatment manufacturers is further boosting the growth of the infectious enteritis treatment market. However, there are several adverse effects associated with the treatment of infectious enteritis mainly resistance due to antibiotics, which in turn is hampering the growth of the infectious esophageal disorders treatment market. Lack of awareness among people in developing countries will also hamper the growth of   infectious enteritis treatment market.

Infectious Enteritis Treatment Market: Overview

Infectious Enteritis Treatment Market is expected to have robust growth over the forecast period. On the basis of route of administration type, the infectious enteritis treatment market is majorly dominated by the oral segment as this is the first line of treatment for infectious enteric disease. Among the drug type segment, antibiotic segment is expected to dominate the infectious enteritis treatment market due to maximum availability of products.  By end user, retail pharmacy is expected to dominate the infectious enteritis treatment market.

Infectious Enteritis Treatment Market: Regional Outlook

The North America is accounted for significant market share in terms of revenue and is expected to dominate the infectious enteritis treatment market over the forecast period. This is attributed to the increasing prevalence of infectious enteric disorders like diarrhoea in the region. Also, intensive research and development activities to expand the therapeutic application of infectious enteritis treatment drugs are further aiding in the growth of the infectious enteritis treatment market in the region. The Asia Pacific is expected to register prominent growth over the forecast period, owing to the increasing patients suffering from enteric infections and rising awareness of people towards the early treatment of infectious disorders. The higher disposable income of the people and increasing healthcare per capita is also contributing to the infectious infectious enteritis treatment market growth. The Middle East and Africa are projected to witness the least growth in the infectious enteritis treatment market, owing to the lack of awareness and least availability of infectious enteritis treatment in the region.

Infectious Enteritis Treatment Market: Key Players

The major in infectious enteritis treatment market are Abbott Laboratories, Baxter International, Pfizer, Bristol-Myers Squibb, Actelion Pharmaceuticals, Merck & Company, Lonza, BioGaia, ZBiotics company, Evolve Biosystems etc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Infectious Enteritis Treatment Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Infectious Enteritis Treatment Market: Segmentation

The Infectious Enteritis Treatment Market can be segmented into Product type, Drug Type and End User

Based on by route of administration, the infectious enteritis treatment market is segmented into the following

  • Oral
  • Injectable

Based on drug type, the infectious enteritis treatment market is segmented into the following-

  • Antibiotics
  • Ampicillin
  • Chloramphenicol
  • Trimethoprim-sulfamethoxazole
  • Antivirals
  • Probiotics

Based on end user, the infectious enteritis treatment market is segmented into the following:

  • Hospital pharmacies
  • Retail pharmacy
  • Drug stores
  • Online Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Infectious Enteritis Treatment Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Infectious Enteritis Treatment Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology